Live by the EpiPen, die by the EpiPen
Zach Shallbetter

To be very clear — it’s a medical device patent, not a pharmaceutical patent, at issue here. If one is going to be encouraging legislative fixes, one should make sure that they actually address the problem at hand.

Like what you read? Give Charles Duffy a round of applause.

From a quick cheer to a standing ovation, clap to show how much you enjoyed this story.